Overview

Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of AT-1501 compared with tacrolimus in patients undergoing kidney transplantation.
Phase:
Phase 2
Details
Lead Sponsor:
Eledon Pharmaceuticals
Treatments:
Tacrolimus